TY - JOUR
T1 - Histone acetylation in reproductive organs
T2 - Significance of histone deacetylase inhibitors in gene transcription
AU - Uchida, Hiroshi
AU - Maruyama, Tetsuo
AU - Arase, Toru
AU - Ono, Masanori
AU - Nagashima, Takashi
AU - Masuda, Hirotaka
AU - Asada, Hironori
AU - Yoshimura, Yasunori
N1 - Funding Information:
WE ARE GRATEFUL to Ms Rei Sakurai for her tech-nical assistance and to Ms Shino Kuwabara for her secretarial work. This work was supported in part by grants-in-aid for scientific research C(2)16591683 (to H.U.) and C(2)13671743 (to T.M.) from the Ministry of Education, Science, Sports, and Culture of Japan; and grants from Keio University for Encouragement of Young Medical Scientists, Keio Medical Association, and Mitsukoshi Health and Welfare Foundation.
PY - 2005/6
Y1 - 2005/6
N2 - Acetylation of histones is cooperatively regulated by two groups of enzymes, histone acetyltransferases and histone deacetylases. Histone acetylation status plays a fundamental role in the level of gene transcription; numerous studies have demonstrated that histone deacetylase inhibitors cause cell growth arrest, apoptosis, and differentiation in various cells including human mammary gland and endometrial cells by altering transcription of a small number of genes. A recent study has also shown that a highly acetylated histone status alters cell motility. After the present review of the published reports on the mechanisms underlying histone acetylation and in vitro effects of histone deacetylase inhibitors, we conclude that this class of agents may have potential not only as anticancer drugs, but also as inducers of differentiation and/or motility for benign gynecologic conditions such as endometriosis and disorders of endometrial differentiation and dysfunction.
AB - Acetylation of histones is cooperatively regulated by two groups of enzymes, histone acetyltransferases and histone deacetylases. Histone acetylation status plays a fundamental role in the level of gene transcription; numerous studies have demonstrated that histone deacetylase inhibitors cause cell growth arrest, apoptosis, and differentiation in various cells including human mammary gland and endometrial cells by altering transcription of a small number of genes. A recent study has also shown that a highly acetylated histone status alters cell motility. After the present review of the published reports on the mechanisms underlying histone acetylation and in vitro effects of histone deacetylase inhibitors, we conclude that this class of agents may have potential not only as anticancer drugs, but also as inducers of differentiation and/or motility for benign gynecologic conditions such as endometriosis and disorders of endometrial differentiation and dysfunction.
KW - Histone acetylation
KW - Histone deacetylase inhibitor
KW - Suberoylanilide hydroxamic acid
KW - Trixchostatin A
UR - http://www.scopus.com/inward/record.url?scp=21344445065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=21344445065&partnerID=8YFLogxK
U2 - 10.1111/j.1447-0578.2005.00101.x
DO - 10.1111/j.1447-0578.2005.00101.x
M3 - Review article
AN - SCOPUS:21344445065
SN - 1445-5781
VL - 4
SP - 115
EP - 122
JO - Reproductive Medicine and Biology
JF - Reproductive Medicine and Biology
IS - 2
ER -